| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680475 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2018 | 9 Pages |
Abstract
Our results question the ability of selective serotonin reuptake inhibitor therapy to ameliorate established Aβ pathology. The severe adverse effect of paroxetine may discourage its use for disease-modifying purposes in Alzheimer's disease.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Maurizio Severino, Mithula Sivasaravanaparan, Louise Ã. Olesen, Christian U. von Linstow, Athanasios Metaxas, Elena V. Bouzinova, Asif Manzoor Khan, Kate L. Lambertsen, Alicia A. Babcock, Jan Bert Gramsbergen, Ove Wiborg, Bente Finsen,